Biogen (BIIB) PT Lowered to $355 at Leerink Partners on Reduced Aducanumab Probability of Success

Go back to Biogen (BIIB) PT Lowered to $355 at Leerink Partners on Reduced Aducanumab Probability of Success
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 222.01 +2.94 (1.34%)
Previous Close $219.07    52 Week High $333.65 
Open $219.22    52 Week Low $223.02 
Day High $222.81    P/E 28.43 
Day Low $219.00    EPS $7.81 
Volume 50,527